Blue Cross and Blue Shield of Georgia Introduces New Individua... ( Individual PPO Products Offer Co...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Blue Cross and Blue Shield of Georgia Introduces New Individual Products

Date:6/24/2008

Individual PPO Products Offer Cost-Effective Choices for Georgia's

Uninsured Population

ATLANTA, June 24 /PRNewswire/ -- Today, Blue Cross and Blue Shield of Georgia (BCBSGa) introduced two suites of PPO products called SmartSense and Premier that will provide Georgians with more affordable options for individual insurance.

The SmartSense plan is designed for consumers who are price conscious and want solid protection to cover the essentials. "Georgians who are seeking a health plan that offers affordability and provides coverage for routine services that can help them improve or maintain their health, now have another option, with premiums for SmartSense ranging from as little as $36.82 to $175.64 per month for a healthy 25-year-old male," said Monye Connolly, president of BCBSGa. The SmartSense plans provide coverage for up to three physician office visits a year before a member has to meet a deductible, some preventive benefits and a choice of prescription drug coverage options.

The Premier plan is designed for customers who want the security of a comprehensive benefit design with lower out of pocket costs. This plan is also a good choice for families with children, or those planning to have children. The Premier plan provides unlimited coverage for office visits before having to meet a deductible, provides preventive benefits, comprehensive prescription coverage and offers the ability to add maternity coverage.

SmartSense and Premier provide protection against expensive and unexpected medical bills. "These plans were designed for those consumers who recognize the importance of health coverage, but need flexibility when it comes to cost," said Connolly. "The plans offer a variety of deductibles that will help consumers find a premium they can afford."

"I would like to thank Blue Cross and Blue Shield of Georgia for providing these new and innovative products," said Georgia Insurance and Safe
'/>"/>

SOURCE Blue Cross and Blue Shield of Georgia, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. American Red Cross and NSF Scrub Club(R) Announce Collaborative Agreement
2. Newly Formed Consortium to Combat Medical Fraud Announces National Agenda to Intensify Fight Against Health Care Fraud Goals: Collaboration Across Industries; Alignment of Resources; Increased Awareness Among Public and Private Stakeholders Including Fede
3. Raven-Symone and Vivica A. Fox Play for the American Red Cross on NBCs Celebrity Family Feud
4. 12th Annual Fetal Surgery Family Reunion Gathers Families From Across the U.S. and Canada
5. The American Red Cross Urges Safety in States Affected by Flooding
6. July 11 Nomination Deadline Nears for Blue Cross Blue Shield of Michigan Annual Claude Pepper Community Service Awards
7. 3M Company Supports Red Cross Relief Efforts through Red Cross Racing
8. Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions
9. Blue Cross and Blue Shield Companies Anti-Fraud Units Recover and Save More Than $249 Million In 2007
10. Blue Cross Blue Shield of Hawaii and American Well Bring Online Care to the State of Hawaii
11. BlueCross $1.5 Million Nursing Scholarships to Ease Nursing Faculty Shortage

Post Your Comments:

[0] Soy Beneficial for Breast Cancer Survivors: Study [1] Researchers Use New Techniques to Assess PTSD [0] Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)[1] Patient Safety Organization (PSO) Participation: What Every Provider Needs to Know [1] Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)

Other Medicine News:Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2 Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3 Health News:Stigma Keeps Teens From Depression Treatment 2 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 2 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 3 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 4 Health News:Gyminee Raises 525K and Relaunches as DailyBurn 2 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 2 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 3 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 4 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 5 Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 2 Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 3

Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex Stigma Keeps Teens From Depression Treatment The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite Gyminee Raises 525K and Relaunches as DailyBurn Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making

Breaking Medicine Technology:Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 1 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 2 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 3 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 4 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 1 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 2 10 students receive scholarships for outstanding work in public health systems research 50092 1

[0] Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities [0] Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 [0] Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective

Other Medicine Technology:XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2 XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3 XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5

XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years

Medicine Products:

STA STACHROM PROTEIN C ASSERACHROM PROTEIN C STA ROTACHROM HEPARIN 4 STA DEFICIENT X

Blue Cross and Blue Shield of Georgia Introduces New Individua...( Individual PPO Products Offer Co...),Health